The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISHL12 2022 | Biomarkers being explored in Hodgkin lymphoma: the role of ctDNA
Arjan Diepstra, PhD, University of Groningen, Groningen, The Netherlands, discusses novel biomarkers being explored in Hodgkin lymphoma (HL), drawing focus on circulating tumor DNA (ctDNA). This interview took place at The 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
